Reduce Graft Vs Host Disease
Showing 26 - 50 of >10,000
Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)
Recruiting
- Chronic Graft Versus Host Disease
- Steroid Refractory Graft Versus Host Disease
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Acute Graft-versus-host Disease Trial in Duarte (GDC-8264)
Recruiting
- Acute Graft-versus-host Disease
-
Duarte, CaliforniaCity of Hope National Medical Center
Jan 12, 2023
Chronic GVHD Trial in United States (Ofatumumab)
Completed
- Chronic Graft Versus Host Disease
-
Phoenix, Arizona
- +3 more
Sep 30, 2022
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Graft-versus-host-disease, Graft Vs Host Disease Trial in Saint Louis (Baricitinib)
Recruiting
- Graft-versus-host-disease
- Graft Vs Host Disease
-
Saint Louis, MissouriWashington University School of Medicine
Mar 4, 2022
Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial
Not yet recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
- (no location specified)
Jan 11, 2023
GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)
Recruiting
- Graft Versus Host Disease
- +2 more
- sodium butyrate
-
Seoul, Korea, Republic ofSoonchunhyang University Seoul Hospital
Apr 11, 2023
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
Acute GVHD, Gastrointestinal Tract Acute GVHD, Severe Gastrointestinal Tract Acute GVHD Trial in Los Angeles (Fecal Microbiota
Not yet recruiting
- Acute Graft Versus Host Disease
- +3 more
- Fecal Microbiota Transplantation Capsule
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Sep 16, 2022
Transplant-Related Disorder Trial in Tianjin (Ruxolitinib)
Recruiting
- Transplant-Related Disorder
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jan 28, 2023
Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)
Active, not recruiting
- Chronic Graft vs Host Disease
- Chronic Graft-Versus-Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 29, 2022
MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Busulfan
- +3 more
-
Miami, FloridaMiami Cancer Institute
Jan 10, 2023
Chronic GVHD Trial in Duarte (Belumosudil, Placebo, Prednisone)
Recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Duarte, CaliforniaCity of Hope Site Number : 8400001
Nov 23, 2023
Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)
Recruiting
- Acute Graft Versus Host Disease
- MSCTC-0010 Dose Escalation
-
Kansas City, KansasKansas University Cancer Center
Jan 30, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
GVHD Trial in Chicago (Expressive Writing)
Not yet recruiting
- Graft Versus Host Disease
- Expressive Writing
-
Chicago, IllinoisDepartment of Dermatology, Northwestern University Feinberg Scho
Jan 12, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States
Completed
- Steroid-refractory Acute Graft-versus-Host Disease
- Treatment-refractory Acute Graft-versus-Host Disease
- Neihulizumab (ALTB-168)
-
Duarte, California
- +12 more
Jan 17, 2023
Clinical and Biological Factors Determining Outcomes in Chronic
Recruiting
- Chronic Graft vs Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022